Home › USFDA Tracker › Ipca Laboratories
Ipca Laboratories — USFDA Status
Inspections, Form 483 observations, OAI classifications, warning letters, import alerts and approvals for Ipca Laboratories (NSE: IPCALAB, BSE: 524494), from US FDA records and exchange filings.
60
Compliance score (5 years) · how
4
USFDA-inspected plants on record
0
OAI classifications (5y)
0
Form 483s on record (5y)
0
Open warning letters
Latest USFDA record: USFDA inspection classified VAI — 05 Dec 2025 (Palghar plant). Source: FDA Data Dashboard.
USFDA events by year
2023
2025
NAIVAIForm 483OAIWarning letterImport alertUS approval
Plants
Full USFDA timeline
05 Dec 2025
VAI — minor issues
USFDA inspection classified VAI
Palghar · FEI 3006057101 · Ipca Laboratories Limited, Palghar — Drug Quality Assurance (Drugs)
Source: FDA Data Dashboard ↗
21 Oct 2023
VAI — minor issues
USFDA inspection classified VAI
Ratlam · FEI 3002807297 · Ipca Laboratories Limited, Ratlam — Drug Quality Assurance (Drugs)
Source: FDA Data Dashboard ↗
23 Jun 2023
VAI — minor issues
USFDA inspection classified VAI
Dhar · FEI 3007574780 · Ipca Laboratories Limited, Dhar — Drug Quality Assurance (Drugs)
Source: FDA Data Dashboard ↗
13 Jun 2023
VAI — minor issues
USFDA inspection classified VAI
Ratlam · FEI 3002807297 · Ipca Laboratories Limited, Ratlam — Drug Quality Assurance (Drugs)
Source: FDA Data Dashboard ↗
26 Apr 2023
VAI — minor issues
USFDA inspection classified VAI
Silvassa · FEI 3005977675 · Ipca Laboratories Limited, Silvassa — Drug Quality Assurance (Drugs)
Source: FDA Data Dashboard ↗
📎 Cite this data: Source: PharmaRoz analysis of FDA inspection data and exchange filings, updated 12 Nov 2026 — https://pharmaroz.com/company/ipca